These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 12407428)
1. New concepts about graft-versus-host and graft-versus-leukaemia-reactions. A summary of the 5th International Symposium held in Munich, 21 and 22 March 2002. Munker R; Günther W; Kolb HJ Bone Marrow Transplant; 2002 Nov; 30(9):549-56. PubMed ID: 12407428 [TBL] [Abstract][Full Text] [Related]
2. Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd-25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies. Munker R; Reibke R; Kolb HJ Bone Marrow Transplant; 2006 Nov; 38(9):593-607. PubMed ID: 16980992 [TBL] [Abstract][Full Text] [Related]
3. An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22-24, 2004. Munker R; Schmid C; Madrigal JA; Kolb HJ Bone Marrow Transplant; 2004 Nov; 34(9):767-80. PubMed ID: 15361913 [TBL] [Abstract][Full Text] [Related]
4. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation. Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210 [TBL] [Abstract][Full Text] [Related]
5. [Graft vs. host disease and graft vs. leukemia/tumor effect]. Okamoto S Nihon Rinsho; 2003 Sep; 61(9):1484-7. PubMed ID: 14515713 [No Abstract] [Full Text] [Related]
7. [Allorecognition of the recipient after hematopoietic transplantation]. Tiberghien P; Robinet E; Ferrand C; Saas P; Hervé P Bull Cancer; 2003; 90(8-9):706-10. PubMed ID: 14609760 [TBL] [Abstract][Full Text] [Related]
8. Memory T cells: A helpful guard for allogeneic hematopoietic stem cell transplantation without causing graft-versus-host disease. Huang W; Chao NJ Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):211-219. PubMed ID: 28636890 [TBL] [Abstract][Full Text] [Related]
9. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. Xia G; Truitt RL; Johnson BD Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723 [TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice. Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029 [TBL] [Abstract][Full Text] [Related]
11. Minor histocompatibility antigens: past, present, and future. Spierings E Tissue Antigens; 2014 Oct; 84(4):374-60. PubMed ID: 25262921 [TBL] [Abstract][Full Text] [Related]
12. [Role of NK cells in allogeneic hematopoietic stem cell transplantation--review]. Li XH; Gao CJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):845-8. PubMed ID: 16928336 [TBL] [Abstract][Full Text] [Related]
13. Natural killer receptors and graft-vs.-host/ graft-vs.-leukaemia reactions. Jones DC; Young NT Vox Sang; 2004 Jul; 87 Suppl 2():15-7. PubMed ID: 15209869 [No Abstract] [Full Text] [Related]
14. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction. van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556 [TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease. Natzke AM; Shaw JL; McKeller MR; Emo KL; Mullen CA Biol Blood Marrow Transplant; 2007 Jan; 13(1):34-45. PubMed ID: 17222751 [TBL] [Abstract][Full Text] [Related]
16. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft. Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288 [TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
18. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia. Rowe JM Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451 [TBL] [Abstract][Full Text] [Related]
20. Role of interleukin-15 in umbilical cord blood transplantation. Lin SJ; Yan DC; Lee YC; Kuo ML Int Rev Immunol; 2008; 27(6):518-31. PubMed ID: 19065354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]